You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MBRX Exercise Disclosure
Foster Jonathan P. · SEC Form 4 · Filed Nov 6, 2026
Exercise
Reported value range
Not reported
Foster Jonathan P. Chief Financial Officer
MBRX
Transaction date
Nov 4, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 2 days later
MBRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 41 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-035617
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$84.6
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moleculin Biotech, Inc. MBRX Current | Exercise | Nov 4, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX | Disposition | Nov 4, 2026 | $84.6 |
| Moleculin Biotech, Inc. MBRX | Exercise | Nov 4, 2026 | $0 |